New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin treatment were associated with improved PFS in ...

Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Parents today are generally aware of mental health conditions that relate to body image, including common disorders like ...

Social media users were amazed by the item found in the viral clip, with one saying "the nice things these people throw away is incredible." ...

All requests for withdrawal of funds were turned down, with banners at branch gates saying deposits would be paid back in ...

Tyler Reddick looks poised for his best Daytona 500 finish yet, and he's listed at a healthy price just to be the top Toyota ...

Clinical outcomes for ulcerative colitis patients with a prior anti-TNF therapy failure appeared similar with ustekinumab ...

Their past five games have taken him to North Africa, Italy, France and Germany. The latest entry, Sniper Elite: Resistance, ...

Abstract Title: Safety and Efficacy of DYNE-101 in Adults with DM1: Phase 1/2 ACHIEVE Trial Data Date and Time: Wednesday, March 19, at 12:30-12:45 p.m. CT Presenter: James Lilleker M.D., Neurologist, ...

W e recently paid a visit to Osaka, Japan, where we had the pleasure of sitting down to chat with the developers of the ...

(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Poster Session A: Prostate Cancer. Dr. Moein Moradpour ...